Topical Immunotx for Actinic Keratosis May Prevent Cancer
MONDAY, March 25, 2019 -- A short course of calcipotriol plus 5-fluorouracil (5-FU) treatment for actinic keratosis (AK) is associated with induction of robust T cell immunity and reduced development of squamous cell carcinoma (SCC) within three...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Pharmaceuticals | Skin Cancer | Squamous Cell Carcinoma | Taclonex